Mark J. Gergen

2016 - Mirati Therapeutics

In 2016, Mark J. Gergen earned a total compensation of $2M as Former Executive Vice President and Chief Operations Officer at Mirati Therapeutics, a 87% increase compared to previous year.

Compensation breakdown

Option Awards$1,179,389
Salary$283,909
Other$512,747
Total$1,976,045

Gergen received $1.2M in option awards, accounting for 60% of the total pay in 2016.

Gergen also received $283.9K in salary and $512.7K in other compensation.

Rankings

In 2016, Mark J. Gergen's compensation ranked 4,947th out of 14,075 executives tracked by ExecPay. In other words, Gergen earned more than 64.9% of executives.

ClassificationRankingPercentile
All
4,947
out of 14,075
65th
Division
Manufacturing
1,765
out of 5,486
68th
Major group
Chemicals And Allied Products
557
out of 1,900
71st
Industry group
Drugs
413
out of 1,543
73rd
Industry
Pharmaceutical Preparations
328
out of 1,173
72nd
Source: SEC filing on April 20, 2017.

Gergen's colleagues

We found five more compensation records of executives who worked with Mark J. Gergen at Mirati Therapeutics in 2016.

2016

Charles Baum

Mirati Therapeutics

Chief Executive Officer

2016

James Christensen

Mirati Therapeutics

Chief Scientific Officer

2016

Isan Chen

Mirati Therapeutics

Executive Vice President and Chief Medical and Development Officer

2016

Jamie Donadio

Mirati Therapeutics

Chief Financial Officer

2016

Chris LeMasters

Mirati Therapeutics

Executive Vice President and Chief Business Officer

News

In-depth

You may also like